Koehler Pharmaceutical Asia, a joint venture between Dr Franz Koehler Chemie GmbH and C. Melchers GmbH & Co.KG, Singapore Branch, combines decades of expertise from two leading organizations in the pharmaceutical and healthcare sectors.

Our flagship product, CUSTODIOL HTK solution is approved for perfusion and irrigation of kidneys, liver, pancreas, and heart, ensuring optimal conditions for successful transplantation, and supports critical cardiac surgeries as a cardioplegia solution.

We are committed to providing tailored solutions, exceptional support, and unmatched service, empowering healthcare professionals to deliver the highest standard of care.